Congress funds open-access biotech labs to compete with China, boost rural jobs

What it does

This bill directs the Secretary of Commerce to establish at least 3 regional, nonprofit, open-access facilities where companies and researchers can test and scale up bioindustrial technologies—converting agricultural waste, algae, and other feedstocks into chemicals, fuels, and materials. The facilities will offer shared fermentation equipment and infrastructure on an equitable basis to both public and private entities, with $345 million authorized for 2026–2028 and $117 million for 2029–2030. The goal is to position the U.S. as a leader in biotechnology innovation and create jobs, especially in rural areas.

Why we flagged it

The bill establishes federally funded, nonprofit, open-access shared facilities for bioindustrial R&D and scale-up. This is a classic public-goods investment model—reducing private capital barriers and spreading innovation benefits across the sector rather than concentrating them in one firm or narrow group.

What the text implies

• Facilities will operate under a 10-year sunset clause, but successful ones may continue indefinitely at Secretary's discretion—creating ongoing operational uncertainty and potential for political influence over which facilities survive.
• Intellectual property created by non-federal employees is protected under 'applicable IP laws' and 'terms of agreement with the Secretary'—the bill does not specify those terms, leaving room for future restrictions on commercialization rights or data access.
• Cost-sharing and co-funding arrangements with private sector are encouraged but not mandated—facilities may become dependent on private capital, potentially compromising the 'open access' mandate if private funders demand preferential access.
• Site selection criteria and funding allocation methodologies are to be finalized in a 180-day implementation plan, not in the statute itself—Congress delegates key policy decisions to the Executive, reducing legislative oversight.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill funds shared public infrastructure (open-access facilities) that reduces barriers to entry for startups and smaller firms, accelerates innovation in a strategically important sector, and explicitly prioritizes rural job creation and workforce development. The open-access mandate and nonprofit operation model ensure broad participation rather than capture by a single company.

Who stands to gain

• nonprofit organizations and universities (planning and implementation grants)
• bioindustrial companies (access to shared infrastructure at subsidized cost)
• construction and equipment vendors (facility buildout contracts)
• agricultural and biotech sectors (reduced R&D capital requirements)

Named in the bill

Secretary of Commerce, Assistant Secretary for Economic Development, Department of Energy, Department of Defense, BioMADE, Department of Agriculture, Department of Transportation, National Science Foundation, National Laboratories

Where it stands

2 cosponsors: 2 Democrats.

• May 20, 2026 — Introduced · Congress.gov: “Introduced in House”
• May 20, 2026 — Referred to House Committee on Financial Services and House Committee on Transportation and Infrastructure · Congress.gov: “Referred to the Committee on Transportation and Infrastructure, and in addition to the Committee on Financial…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.